It stimulates insulin production to manage glucose levels, slows digestion to prevent spikes, and signals your brain to enhance fullness
Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: A prospective study
Their pharmacokinetics, dosing schedules, and clinical applications differ, making individualized treatment decisions important
A proteolysis-resistant MRI-visible nanoparticle formulation of GLP-1RA (nano-GLP-1RA) was engineered to target GLP-1Rexpressing cells within atherosclerotic lesions ( In ApoE/ mice, nano-GLP-1RA selectively accumulated in plaque-resident inflammatory and de-differentiated smooth muscle cells, consistent with GLP-1Rexpressing populations observed in human plaques ( Taken together, while imaging and omics technologies offer powerful tools to characterize vascular biology, their integration with GLP-1RA therapy for patient stratification remains an emerging concept that requires further clinical validation
Figure 3 The G6PD5.4 and G6PD5.5 proteoforms localize to different subdomains of the ER To determine the exact subcellular localization of the alternative G6PD5 proteoforms, the GFP- and OFP-based reporter fusions were used for co-expression with oppositely labeled organelle markers
